隐秘过渡期间的非线性进展确定了癌症的致死率
bioRxiv : the preprint server for biology
|May 7, 2024
概括
癌症查假定瘤的增长是线性的,但这项研究显示了非线性的进展. 早期乳腺癌检测可能会错过已经恶性癌症的癌症,这是由于关键的隐性过渡.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 瘤发生的起源
背景情况:
- 目前的癌症查模式依赖于瘤生长和恶性进展的线性模型.
- 历史数据表明,恶性进展与瘤生长无关,这可能解释了早期检测增加而不减少转移.
- 这种差异凸显了理解瘤发育和进展的局限性.
研究的目的:
- 研究HER2+乳腺癌中瘤发育和恶性进展的非线性动态.
- 确定瘤发育不同阶段之间的过渡率,从转变细胞到症状瘤.
- 挑战线性进展模型,这是当前癌症查策略的基础.
主要方法:
- 利用癌症彩虹鼠标模型来追踪数百万个转基因野外细胞和数千个瘤的血统.
- 采用动态模型来估计从野外细胞到屏检测到的瘤,然后到症状瘤的过渡率.
- 进行了移植试验实验,以评估瘤进展和恶性瘤.
主要成果:
- 与从屏幕检测到症状瘤的进展相比,转化场细胞进展到屏幕检测到瘤的可能性明显低.
- 确定了一个关键的"隐秘过渡"阶段,在这个阶段,转变的细胞成为真正的瘤.
- 证明在神秘过渡期间或之前的非线性进展可以导致查时检测到的致命癌症.
结论:
- 癌症的进展不是严格的线性,有关键的隐性过渡显著影响恶性瘤.
- 目前的查模型可能不足,因为在检测前可能出现非线性,快速的进展.
- 了解这些非线性动态对于改善癌症查和治疗策略至关重要.
更多相关视频
08:50Longitudinal Morphological and Physiological Monitoring of Three-dimensional Tumor Spheroids Using Optical Coherence Tomography
Published on: February 9, 2019
7.7K
07:12Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
Published on: July 7, 2016
20.3K
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
